Geographic Variation in the Prevalence of High-Risk Medication Use Among Medicare Part D Beneficiaries by Hospital Referral Region

被引:1
|
作者
Chinthammit, Chanadda [1 ,2 ]
Bhattacharjee, Sandipan [3 ]
Axon, David R. [3 ]
Slack, Marion [3 ]
Bentley, John P. [4 ]
Warholak, Terri L. [3 ]
Wilson, Debbie L. [5 ]
Lo-Ciganic, Wei-Hsuan [5 ,6 ]
机构
[1] Univ Arizona, Coll Pharm, Dept Pharmaceut Sci, Tucson, AZ 85721 USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
[3] Univ Arizona, Coll Pharm, Dept Pharm Practice & Sci, Tucson, AZ 85721 USA
[4] Univ Mississippi, Sch Pharm, Dept Pharm Adm, University, MS 38677 USA
[5] Univ Florida, Coll Pharm, Dept Pharmaceut Outcomes & Policy, POB 100496,1225 Ctr Dr,HPNP Bldg,Rm 3338, Gainesville, FL 32610 USA
[6] Univ Florida, Coll Pharm, Ctr Drug Evaluat & Safety, Gainesville, FL 32610 USA
来源
关键词
POTENTIALLY INAPPROPRIATE MEDICATION; ELDERLY-PATIENTS; BEERS CRITERIA; STAR RATINGS; OLDER-ADULTS; CARE; PHARMACY; QUALITY; IMPACT;
D O I
10.18553/jmcp.2020.26.10.1309
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
BACKGROUND: Understanding geographic patterns of high-risk medication (HRM) prescribed and dispensed among older adults may help the Centers for Medicare & Medicaid Services and their partners develop and tailor prevention strategies. OBJECTIVE: To compare the geographic variation in the prevalence of HRM use among Medicare Part D beneficiaries from 2011 to 2013, for Medicare Advantage Prescription Drug (MA-PD) plans and stand-alone Prescription Drug Plans (PDPs). METHODS: This retrospective study used the data of a 5% national Medicare sample (2011-2013). Beneficiaries were included in the study if they were aged >= 65 years, continuously enrolled in MA-PDs or PDPs (similar to 1.3 million each year), and had 2 prescriptions for the same HRM (e.g., amitriptyline) prescribed and dispensed during the year based on the Pharmacy Quality Alliance's (PQA) quality measures for HRM use. Multivariable logistic regression was used to estimate adjusted annual HRM use rates (i.e., adjusted predictions, average marginal predictions, or model-adjusted risk) across 306 Dartmouth Atlas of Health Care hospital referral regions (HRRs), controlling for sociodemographic, health-status, and access-to-care factors. RESULTS: Among eligible beneficiaries each year (1,161,076 in 2011, 1,237,653 in 2012, and 1,402,861 in 2013), nearly 40% were enrolled in MA-PD plans, whereas the remaining 60% were in PDP plans. The adjusted prevalence of HRM use significantly decreased among Medicare beneficiaries enrolled in MA-PD (13.1%-8.4%, P<0.001) and PDP (16.2%-12.2%, P<0.001) plans from 2011 to 2013. For MA-PD and PDP beneficiaries, HRM users were more likely to be (all P<0.001) the following: female (MA-PD: 70.4% vs. 59.9%; PDP: 72.8% vs. 62.5%); White (MA-PD: 84.6% vs. 81.4%; PDP: 86.6% vs. 85.3%); with low-income subsidy or dual eligibility for Medicaid (MA-PD: 22.3% vs. 16.6%; PDP: 29.2% vs. 23.3%); and disabled (MA-PD: 15.6% vs. 8.7%; PDP: 15.4% vs. 8.5%) compared with non-HRM users in 2013. In 2013, significant geographic variation existed, with the ratios of 75th-25th percentiles of HRM use rates across HRRs as 1.42 for MA-PDs and 1.31 for PDPs. For MA-PDs, the top 5 HRRs with the highest HRM use rates in 2013 were Casper, WY (20.4%), Waco, TX (16.7%), Lubbock, TX (15.7%), Santa Barbara, CA (15.2%), and Temple, TX (15.1%); for PDP5, they were Lawton, OK (18.8%), Alexandria, LA (18.8%), Lake Charles, LA (18.6%), Oklahoma City, OK (18.0%), and Slidell, LA (18.0%). CONCLUSIONS: Substantial geographic variation exists in the prevalence of HRM use among older adults in Medicare, regardless of prescription drug plan. Areas with high prevalence of HRM use may benefit from targeted interventions (e.g., medication therapy management monitoring or alternative medication substitutions) to prevent potential adverse consequences. Copyright (C) 2020, Academy of Managed Care Pharmacy. All rights reserved.
引用
收藏
页码:1309 / 1316
页数:8
相关论文
共 50 条
  • [21] Characteristics of New Opioid Use Among Medicare Beneficiaries: Identifying High-Risk Patterns
    Raman, Sudha R.
    Bush, Christopher
    Karmali, Ruchir N.
    Greenblatt, Lawrence H.
    Roberts, Andrew W.
    Skinner, Asheley C.
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2019, 25 (09): : 966 - 972
  • [22] Prevalence and Persistence of Cost-Related Medication Nonadherence Among Medicare Beneficiaries at High Risk of Hospitalization
    De Avila, Jorge L.
    Meltzer, David O.
    Zhang, James X.
    [J]. JAMA NETWORK OPEN, 2021, 4 (03)
  • [23] Medication Use and Adherence Among Elderly Medicare Beneficiaries With Diabetes Enrolled in Part D and Retiree Health Plans
    Stuart, Bruce
    Simoni-Wastila, Linda
    Yin, Xianghua
    Davidoff, Amy
    Zuckerman, Ilene H.
    Doshi, Jalpa
    [J]. MEDICAL CARE, 2011, 49 (05) : 511 - 515
  • [24] New psychotropic medication use among Medicare beneficiaries with dementia after hospital discharge
    Growdon, Matthew E.
    Gan, Siqi
    Yaffe, Kristine
    Lee, Alexandra K.
    Anderson, Timothy S.
    Muench, Ulrike
    Boscardin, W. John
    Steinman, Michael A.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2023, 71 (04) : 1134 - 1144
  • [25] Predictors of High-Risk Prescribing Among Elderly Medicare Advantage Beneficiaries
    Cooper, Alicia L.
    Dore, David D.
    Kazis, Lewis E.
    Mor, Vincent
    Trivedi, Amal N.
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2014, 20 (10): : E469 - +
  • [26] Geographic Variation in Cardiovascular Procedure Use Among Medicare Fee-for-Service vs Medicare Advantage Beneficiaries
    Matlock, Daniel D.
    Groeneveld, Peter W.
    Sidney, Steve
    Shetterly, Susan
    Goodrich, Glenn
    Glenn, Karen
    Xu, Stan
    Yang, Lin
    Farmer, Steven A.
    Reynolds, Kristi
    Cassidy-Bushrow, Andrea E.
    Lieu, Tracy
    Boudreau, Denise M.
    Greenlee, Robert T.
    Tom, Jeffrey
    Vupputuri, Suma
    Adams, Kenneth F.
    Smith, David H.
    Gunter, Margaret J.
    Go, Alan S.
    Magid, David J.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (02): : 155 - 162
  • [27] Geographic Variation in Stroke Rates and Oral Anticoagulation Use among Medicare Beneficiaries with Atrial Fibrillation
    Hernandez, Inmaculada
    Saba, Samir
    Zhang, Yuting
    [J]. CIRCULATION, 2018, 137
  • [28] Generic alendronate use among medicare beneficiaries: are part d data complete?
    Yun, Huifeng
    Curtis, Jeffrey R.
    Saag, Kenneth
    Kilgore, Meredith
    Muntner, Paul
    Smith, Wilson
    Matthews, Robert
    Wright, Nicole
    Morrisey, Michael A.
    Delzell, Elizabeth
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 (01) : 55 - 63
  • [29] EFFECTS OF THE MEDICARE PART D COMPREHENSIVE MEDICATION REVIEW ON MEDICATION ADHERENCE AMONG BENEFICIARIES WITH ALZHEIMER'S DISEASE
    Dong, X.
    Tsang, S.
    Zhao, S.
    Browning, J.
    Wan, J.
    Chisholm-Burns, M.
    Finch, C. K.
    Tsao, J. W.
    Hines, L.
    Wang, J.
    [J]. VALUE IN HEALTH, 2021, 24 : S150 - S150
  • [30] Cost-Related Medication Nonadherence Among Beneficiaries With Depression Following Medicare Part D
    Zivin, Kara
    Madden, Jeanne M.
    Graves, Amy J.
    Zhang, Fang
    Soumerai, Stephen B.
    [J]. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2009, 17 (12): : 1068 - 1076